Table 3.
Double- and triple-combination therapy trials in chronic and advanced phases of myelofibrosis
Double- and triple-combination therapy trials in chronic and advanced phases of myelofibrosis

* Stage 2 of the phase II trial will only evaluate PRM-151 as monotherapy.